| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/25/2004 | US20040057961 Human t cell response to mhc-binding motif clusters |
| 03/25/2004 | US20040057960 Activating hepatitis C virus (HCV)-specific T cells, including CD4+ and CD8+ T cells, using fusion proteins comprising HCV, NS3, NS4, NS5a, and NS5b polypeptides, polynucleotides encoding such fusion proteins; immunogens |
| 03/25/2004 | US20040057959 Recombitope peptides |
| 03/25/2004 | US20040057954 Tumor necrosis factor antagonists and their use in endometriosis |
| 03/25/2004 | US20040057953 Modified peptides as therapeutic agents |
| 03/25/2004 | US20040057933 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 03/25/2004 | US20040057932 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 03/25/2004 | US20040057931 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 03/25/2004 | US20040057926 Administering inhibitor of arginase I, an inhibitor of a cationic amino acid transporter Y+ receptor or a liposomal formulation of arginine or an arginine provider to a mammal wherein an immune response in mammal is increased |
| 03/25/2004 | US20040057925 Methods of enhancing bioactivity of chemokines |
| 03/25/2004 | US20040055620 Killing, degradation , vaporization of drainage pan, heat exchanger coils |
| 03/25/2004 | DE10306085A1 New nucleic acid encoding splice variant of protein kinase A anchor protein, useful e.g. for identifying agents for treating diabetes or hypertension, also new polypeptide |
| 03/25/2004 | DE10242663A1 Identifying inhibitors of metastasis or lymphangiogenesis, useful for treating cancer, by in vivo testing for inhibiting the activation of vascular endothelial growth factor receptor-3 |
| 03/25/2004 | DE10242433A1 Chip carrying probes for specific genes, useful for rapid monitoring of organism status, particularly during fermentation |
| 03/25/2004 | DE10242016A1 Identifying blood-brain barrier protein, useful e.g. as drug transporter and for treatment or diagnosis, by subtractive hybridization using cDNA from brain capillary cells |
| 03/25/2004 | DE10241681A1 Forisomen, Verfahren zu ihrer Isolierung und ihre Verwendung als molekulare Arbeitsmaschine Forisomes, methods for their isolation and their use as molecular machine |
| 03/25/2004 | CA2799437A1 Method of producing hydroxyalkyl starch derivatives |
| 03/25/2004 | CA2507621A1 Crystal structure of an angiotensin-converting enzyme (ace) and uses thereof |
| 03/25/2004 | CA2500967A1 Transgenic cancer models in fish |
| 03/25/2004 | CA2499078A1 Regulating .beta.-catenin levels |
| 03/25/2004 | CA2499014A1 Lactoferrin compositions and methods of wound treatment |
| 03/25/2004 | CA2498928A1 Rb pathway and chromatin remodeling genes that antagonize let-60 ras signaling |
| 03/25/2004 | CA2498784A1 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 03/25/2004 | CA2498770A1 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 03/25/2004 | CA2498751A1 Nell-1 enhanced bone mineralization |
| 03/25/2004 | CA2498723A1 Design of chemokine analogs for the treatment of human diseases |
| 03/25/2004 | CA2498614A1 Analyzing nerve cell damage |
| 03/25/2004 | CA2498583A1 Biochemical methods for measuring metabolic fitness of tissues or whole organisms |
| 03/25/2004 | CA2498525A1 Process for manufacturing crystals of growth hormone |
| 03/25/2004 | CA2498502A1 Recombinant clostridial toxin fragments with proteolytic activation |
| 03/25/2004 | CA2498367A1 Viral deconstruction through capsid assembly in vitro |
| 03/25/2004 | CA2498274A1 Compositions and methods for the diagnosis of immune related diseases using pro7 |
| 03/25/2004 | CA2498249A1 Ostertagia vaccine |
| 03/25/2004 | CA2498055A1 Aspartyl protease inhibitor as a nematode allergen |
| 03/25/2004 | CA2498044A1 Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
| 03/25/2004 | CA2498008A1 Novel composition and methods for the treatment of immune related diseases |
| 03/25/2004 | CA2498004A1 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | CA2498000A1 Use of tumor-associated kinase (task) 110 antagonists for treating pancreatic cancers |
| 03/25/2004 | CA2497890A1 A mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism |
| 03/25/2004 | CA2497793A1 Flj20647s as modifiers of the p21 pathway and methods of use |
| 03/25/2004 | CA2497790A1 Rors as modifiers of the p21 pathway and methods of use |
| 03/25/2004 | CA2497661A1 Compositions and methods for the diagnosis of immune related diseases using pro71061 |
| 03/25/2004 | CA2497356A1 Nucleic acid sequences encoding novel point mutations on mglur2 and mglur3 |
| 03/25/2004 | CA2497337A1 Novel composition and methods for the treatment of psoriasis |
| 03/25/2004 | CA2497334A1 Novel compositions and methods for the treatment of immune related diseases |
| 03/25/2004 | CA2497330A1 Novel compositions and methods for the treatment of immune-related diseases |
| 03/25/2004 | CA2497226A1 Pharmaceutical compositions and medical treatments comprising notch ligand proteins |
| 03/25/2004 | CA2496318A1 Hydroxyalkyl starch derivatives |
| 03/25/2004 | CA2496317A1 Method of producing hydroxyalkyl starch derivatives |
| 03/25/2004 | CA2496213A1 Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
| 03/25/2004 | CA2495252A1 Identification of sequences particularly useful for the diagnosis and identification of therapeutic targets for osteoarthritis |
| 03/25/2004 | CA2495242A1 Hasylated polypeptides, especially hasylated erythropoietin |
| 03/25/2004 | CA2494116A1 Adenoviral va1 pol iii expression system for rna expression |
| 03/25/2004 | CA2489405A1 Screening method of agents for increasing insulin content |
| 03/24/2004 | EP1400809A1 Test for caries susceptibility: detection of the IgA levels in saliva specimens |
| 03/24/2004 | EP1400596A1 Androgen receptor complex-associated protein |
| 03/24/2004 | EP1400593A1 Novel promoter |
| 03/24/2004 | EP1400592A1 Streptococcus pneumoniae polynucleotides and sequences |
| 03/24/2004 | EP1400591A1 Agent for treatment of exocrine gland disorders and transgenic mouse useful for screening the same |
| 03/24/2004 | EP1400536A1 Method for making humanized antibodies |
| 03/24/2004 | EP1400533A1 HASylated polypeptides, especially HASylated erythropoietin |
| 03/24/2004 | EP1400532A1 M. paratuberculosis specific ABC-transporter operon |
| 03/24/2004 | EP1400252A1 Methods and compositions for healing and repair of articular cartilage |
| 03/24/2004 | EP1399850A2 Hla ligand database utilizing predictive algorithms and methods of making and using same |
| 03/24/2004 | EP1399744A2 Epf receptor assays, compounds and therapeutic compositions |
| 03/24/2004 | EP1399740A2 Type 1 diabetes diagnostics and therapeutics |
| 03/24/2004 | EP1399739A2 Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy |
| 03/24/2004 | EP1399587A2 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 03/24/2004 | EP1399586A2 Method to identify genes associated with chronic myelogenous leukemia |
| 03/24/2004 | EP1399584A2 Cancer-linked genes as targets for chemotherapy |
| 03/24/2004 | EP1399583A2 Compositions and methods relating to breast specific genes and proteins |
| 03/24/2004 | EP1399572A2 Gene expression and production of tgf-b proteins including bioactive mullerian inhibiting substance from plants |
| 03/24/2004 | EP1399571A2 Modulating developmental transitions in plants |
| 03/24/2004 | EP1399570A2 Peptides for use as translocation factors |
| 03/24/2004 | EP1399563A2 Moraxella (branhamella) catarrhalis antigens |
| 03/24/2004 | EP1399562A2 Complete nucleotide sequence of staphylococcus aureus ribosomal protein gene, s20 and methods for the identification of antibacterial substances |
| 03/24/2004 | EP1399561A2 Plant disease resistance genes |
| 03/24/2004 | EP1399560A2 Engineered human kunitz-type protease inhibitor |
| 03/24/2004 | EP1399558A2 Vanilloid receptor-related nucleic acids and polypeptides |
| 03/24/2004 | EP1399557A2 Brain expressed gene and protein associated with bipolar disorder |
| 03/24/2004 | EP1399556A2 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 03/24/2004 | EP1399555A2 Rank ligand-binding polypeptides |
| 03/24/2004 | EP1399554A2 Immunoglobulin superfamily proteins |
| 03/24/2004 | EP1399553A2 Polynucleotides encoding cellular transporters and methods of use therof |
| 03/24/2004 | EP1399552A2 G-protein coupled receptor proteins (gpcr) and nucleic acids encoding same |
| 03/24/2004 | EP1399551A2 Method for separating bacterial cells and cell components |
| 03/24/2004 | EP1399549A1 Anticomplement polypeptide from salivary glands of the tick ixodes ricinus |
| 03/24/2004 | EP1399548A2 Conjugate of a transport protein and a protein for modulation of notch signalling |
| 03/24/2004 | EP1399547A1 METHODS AND COMPOSITIONS COMPRISING i RENILLA /i GFP |
| 03/24/2004 | EP1399542A2 Methods for modulating gap junctions |
| 03/24/2004 | EP1399537A2 Therapeutic polypeptides, nucleic acids encoding same and methods of use |
| 03/24/2004 | EP1399499A1 Agent for the prevention and treatment of sexually transmitted diseases-i |
| 03/24/2004 | EP1399483A2 Antibodies to insulin-like growth factor i receptor |
| 03/24/2004 | EP1399482A2 Determination of bone-sialoprotein in bodily fluids for oncological problems |
| 03/24/2004 | EP1399480A2 Multimers of class i major histocompatibility complexes containing modified beta2-microglobulin proteins |
| 03/24/2004 | EP1399479A2 Cation conducting gaba a receptors and their use |
| 03/24/2004 | EP1399478A2 Cancer-testis antigens |
| 03/24/2004 | EP1399477A2 Process of purification of amyloid fibrils |
| 03/24/2004 | EP1399476A1 Use of soluble cytokeratine-1-fragments in diagnostics and therapy |
| 03/24/2004 | EP1399475A2 Mutants of igf binding proteins and methods of production of antagonists thereof |